Blog: Engaging Innovation

September 21, 2023

Watch Now: Supporting the Use of RWD in Oncology Drug Development

https://www.youtube.com/watch?v=39lGyP2CJd8 On September 11, 2023, Friends of Cancer Research (Friends) hosted a public meeting, “Supporting the Use of RWD in Oncology Drug Development”, in Washington, DC. The meeting included a presentation of findings from Friends’ Real-world Response (rw-Response) Pilot and two panel discussions focused on the findings’ regulatory implications for use of RWD and real-world evidence (RWE), and…

Learn More

September 14, 2023

Quarterly Patient Advocacy Newsletter – Q3 2023

Dear Advocates, Welcome to the third edition of the Friends of Cancer Research (Friends) Quarterly Patient Advocate Newsletter. We’re excited to share more about what we’ve been working on at Friends and let you know about upcoming public events and research milestones. Here’s what you can read more about in this newsletter: What’s Happening at…

Learn More

July 20, 2023

Watch Now: Establishing Evidence – New Advancements Using ctDNA

On July 11, 2023, Friends of Cancer Research (Friends) hosted, “Establishing Evidence: New Advancements Using ctDNA”, a public meeting in Washington, DC. The meeting included data readouts for two initiatives: 1) the Baseline circulating tumor DNA (ctDNA) Project, which Friends initiated to address a knowledge gap identified in the Evidentiary Roadmap, included a data readout…

Learn More

June 14, 2023

Quarterly Patient Advocacy Newsletter – Q2 2023

Dear Advocates, Welcome to the second edition of the Friends of Cancer Research (Friends) Quarterly Patient Advocacy Newsletter. Here’s what you can read more about in this newsletter: What’s Happening at Friends in 2023? Friends recently presented new results from several of our initiatives at the American Society of Clinical Oncology (ASCO) Annual Meeting. Here…

Learn More

June 1, 2023

Watch Now: The Next Generation of Cellular Therapies – A Blueprint to Accelerate Development

https://www.youtube.com/watch?v=W2GVgcg8h2E&t=0s On Monday, May 22, Friends of Cancer Research (Friends) hosted a hybrid public meeting titled “The Next Generation of Cellular Therapies: A Blueprint to Accelerate Development.” This meeting built on Friends’ previous work on Cell & Gene Therapies and was the second of two meetings in 2023 to explore next steps in the field.…

Learn More

May 4, 2023

Quarterly Patient Advocate Newsletter – Q1 2023

Welcome to the first edition of the Friends of Cancer Research (Friends) Quarterly Patient Advocate Newsletter. Friends is launching this newsletter in collaboration with our Advisory Advocates to provide a resource for staying up to date on Friends’ projects, learning about upcoming events and conferences, and understanding emerging science and policy impacting the landscape of…

Learn More

March 9, 2023

Watch Now: The Next Generation of Cellular Therapies – Opportunities to Accelerate Development

On Wednesday, March 8, Friends of Cancer Research (Friends) hosted a virtual meeting titled “The Next Generation of Cellular Therapies: Opportunities to Accelerate Development.” This meeting sets the stage for a meeting on May 22 in Washington DC by providing context around the current state of the science and progress in cell therapy development. These…

Learn More

December 1, 2022

Watch Now: Friends of Cancer Research Annual Meeting 2022

On Thursday, November 17, Friends of Cancer Research (Friends) was proud to host our 15th Annual Meeting to address critical issues in the development of new oncology drugs. After our last two Annual Meetings were hosted virtually, we welcomed attendees back safely in-person and virtually. The entire event can be viewed here and a summary…

Learn More

July 28, 2022

Watch Now: Expediting Drug Development – Use of ctDNA as an Early Endpoint

On Wednesday, July 20, Friends of Cancer Research (Friends) hosted a meeting titled “Expediting Drug Development: Use of ctDNA as an Early Endpoint.” Welcoming everyone, Jeff Allen, President & CEO of Friends, provided updates regarding Friends’ ctDNA for Monitoring Treatment Response (ctMoniTR) project , a unique collaboration exploring whether changes in ctDNA levels can indicate clinical…

Learn More

June 29, 2022

rw-Response Pilot Moves Forward with Meeting During ASCO

During the American Society of Clinical Oncology (ASCO) Annual Meeting in June, Friends of Cancer Research (Friends) convened rw-Response Pilot participants to discuss initial findings. This pilot expands on Friends’ previous real-world evidence (RWE) work focused on answering the question: “What real-world endpoints can be evaluated and compared across multiple data sources using a common…

Learn More